| Thu, Nov 5, 2009 | | | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships Wall Street Transcript (Thu, Nov 5)
| | | [video] 3 Stocks I Saw on TV at TheStreet.com (Thu, Nov 5)
| | | Trading Outlook for Advanced Life Sciences Holdings Inc. Issued by InvestorSoup.com GlobeNewswire (Thu, Nov 5)
| | | Value? Growth? Both! at Motley Fool (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | | [video] Battling Cancer at CNBC (Wed, Nov 4)
| | | Merck, now No. 2 drugmaker, set for future buys AP (Wed, Nov 4)
| | | Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo Business Wire (Wed, Nov 4)
| | | [$$] Nothing More Than a Rolling Rally at RealMoney by TheStreet.com (Wed, Nov 4)
| | | Biotech Stocks: Drug stocks mixed; Merck gains on merger at MarketWatch (Wed, Nov 4)
| | | Squeezing the Shorts: Late Earnings Plays at TheStreet.com (Wed, Nov 4)
| | | Roll up for Japan's medical mystery tour at FT.com (Wed, Nov 4)
| | | An Ode to Schering-Plough at Motley Fool (Wed, Nov 4)
| | | Biotech Stocks: Merck, Pfizer, J&J lead drug stocks higher at MarketWatch (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | | Cramer Finds Catalyst for Celgene's Stock at CNBC (Tue, Nov 3)
| | | Is Capitalism Moral? at Forbes.com (Tue, Nov 3)
| | | ViiV vows joint venture will help fight HIV at FT.com (Tue, Nov 3)
| | | Cramer's 'Mad Money' Follow-Up: Nov. 3 at TheStreet.com (Tue, Nov 3)
| | | PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Nov 3)
| | | Low cholesterol may prevent some prostate cancers AP (Tue, Nov 3)
| | | Why You Won't Be Able to Retire at Motley Fool (Tue, Nov 3)
| | | Nice Quarter, Teva. What Will You Buy Next? at Motley Fool (Tue, Nov 3)
| | | [$$] Stock Picks for the Defensive Investor at RealMoney by TheStreet.com (Tue, Nov 3)
| | | A Little Distracted, Are You, Merck? at Motley Fool (Tue, Nov 3)
| | | Lights, Camera, Lipitor! at CNBC (Tue, Nov 3)
| | | Merck to complete $41B purchase of Schering-Plough AP (Tue, Nov 3)
| Add PFE News to My Yahoo!:

| |
|